Literature DB >> 7693076

Surgical treatment of locally advanced thyroid cancer.

K Sugino1, Y Kure, O Ozaki, K Ito, A Matsumoto.   

Abstract

Eighty-four patients with locally advanced thyroid cancer treated during the period from 1965 to 1989 were studied in order to evaluate the appropriateness of radical surgery. There were 57 patients who underwent palliative surgery (palliative group) and 27 patients who underwent radical surgery (radical group). Forty-six of the patients in the palliative group and all 27 in the radical group were aged 40 years or more. The survival rates as analyzed by the Kaplan-Meier method revealed no significant difference between patients aged 40 or more in the palliative group and those in the radical group. The control of local disease, however, was much more difficult in the palliative group. From the view of survival rates, the superiority of radical surgery could not be demonstrated, but radical surgery did control local neck disease better. In the palliative group, the survival rate of patients aged under 40 was significantly better than that of patients aged 40 or more. It may thus be better to avoid radical surgery in patients under 40 if it would result in a severe deterioration in their quality of life.

Entities:  

Mesh:

Year:  1993        PMID: 7693076     DOI: 10.1007/bf00311621

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  9 in total

1.  Intraluminal involvement of the larynx and trachea by thyroid cancer.

Authors:  M Djalilian; O H Beahrs; K D Devine; L H Weiland; L W DeSanto
Journal:  Am J Surg       Date:  1974-10       Impact factor: 2.565

2.  Surgically incurable well-differentiated thyroid carcinoma. Prognostic factors and results of therapy.

Authors:  R L Rossi; B Cady; M L Silverman; M S Wool; S G ReMine; M B Hodge; F A Salzman
Journal:  Arch Surg       Date:  1988-05

3.  Clinicopathologic study of thyroid carcinoma infiltrating the trachea.

Authors:  T Tsumori; K Nakao; M Miyata; M Izukura; Y Monden; M Sakurai; Y Kawashima; K Nakahara
Journal:  Cancer       Date:  1985-12-15       Impact factor: 6.860

4.  Aggressive surgical approach for locally invasive papillary carcinoma of the thyroid in patients over forty-five years of age.

Authors:  Y Fujimoto; T Obara; Y Ito; T Kodama; T Yashiro; T Yamashita; M Nozaki; K Suzuki
Journal:  Surgery       Date:  1986-12       Impact factor: 3.982

5.  Resection of the trachea infiltrated by thyroid carcinoma.

Authors:  T Ishihara; S Yamazaki; K Kobayashi; H Inoue; S Fukai; K Ito; T Mimura
Journal:  Ann Surg       Date:  1982-04       Impact factor: 12.969

6.  Locally invasive, well-differentiated thyroid cancer. 22 years' experience at Memorial Sloan-Kettering Cancer Center.

Authors:  H S Cody; J P Shah
Journal:  Am J Surg       Date:  1981-10       Impact factor: 2.565

7.  Treatment of locally invasive carcinoma of the thyroid: how radical?

Authors:  G P Breaux; O M Guillamondegui
Journal:  Am J Surg       Date:  1980-10       Impact factor: 2.565

8.  Resectional management of airway invasion by thyroid carcinoma.

Authors:  H C Grillo; P Zannini
Journal:  Ann Thorac Surg       Date:  1986-09       Impact factor: 4.330

9.  Locally aggressive differentiated thyroid carcinoma.

Authors:  F Tovi; J Goldstein
Journal:  J Surg Oncol       Date:  1985-06       Impact factor: 3.454

  9 in total
  2 in total

1.  Metastases to the regional lymph nodes, lymph node recurrence, and distant metastases in nonadvanced papillary thyroid carcinoma.

Authors:  K Sugino; Y Kure; H Iwasaki; O Ozaki; T Mimura; A Matsumoto; K Ito
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

2.  The prognostic value of regional lymph node metastases in patients of Guangdong Province, China with differentiated thyroid cancer: A multicenter retrospective clinical study.

Authors:  Lin-Yun He; Wei-Wei Wang; Balde Alpha Ibrahima; Shuai Han; Zhou Li; Zhai Cai; Miao-Liang Chen; Bao-Zhu Chen; Hui-Shi Tan; Hai-Shan Zeng; Xiao-Li Dai; Min-Wei Zhou; Gang-Qing Zhang; Guo-Xin Li
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.